GeneDx recognized for its innovative approach to accelerating genetic diagnosis and transforming the future of healthcare by ending the diagnostic odyssey “Our list of the Most Innovative ...
Hosted on MSN1mon
GeneDx targeted in short report by Grizzly ResearchInvesting.com -- Grizzly Research has shorted GeneDx, a genetic testing company, accusing them of widespread fraud. GeneDx specializes in advanced genomic testing, with a focus on rare and ultra ...
We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...
Reports FY24 revenue $305.5M, consensus $290.82M .”The fourth quarter capped an outstanding year for GeneDx (WGS), as we work to end the diagnostic odyssey with earlier intervention using our ...
GAITHERSBURG, Md., March 13, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision ...
GAITHERSBURG, Md., March 04, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its ...
Hosted on MSN1mon
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call TranscriptGeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript February 18, 2025 GeneDx Holdings Corp. beats earnings expectations. Reported EPS is $0.62, expectations were $0.04.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback